Panic Disorder

临床试验

计划入组 46 人 · 首次发布于 2005 年 7 月 11 日

已完成

NCT00063375

Interactive Computer Treatment for Panic Disorder

计划入组 60 人 · 首次发布于 2003 年 6 月 27 日

已完成

NCT00456768

Efficacy of Treatment for Panic Disorder

计划入组 250 人 · 首次发布于 2007 年 4 月 5 日

药物

查看全部 287 →

Small Molecule

Approved

Fluoxetine(Prozac, Sarafem, Symbyax)

生产企业：Barr laboratories inc, Dr reddys laboratories ltd，另有 29 家

相关疾病：Alcohol Dependency, Anorexia Nervosa (AN)，另有 12 项

C₁₇H₁₈F₃NO · Rx

Small Molecule

Approved

Venlafaxine(Effexor)

生产企业：Wyeth pharmaceuticals inc, Teva pharmaceuticals usa inc，另有 12 家

相关疾病：Generalized Anxiety Disorder, Major Depressive Disorder (MDD)，另有 5 项

C₁₇H₂₇NO₂ · Rx

Small Molecule

Approved

Paroxetine(Paxil, Pexeva)

生产企业：Glaxosmithkline, Apotex inc，另有 11 家

相关疾病：Generalized Anxiety Disorder, Irritable Bowel Syndrome (IBS)，另有 8 项

C₁₉H₂₀FNO₃ · Rx

机构

查看全部 18 →

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

United States

Vanda Pharmaceuticals

United States

Alzamend Neuro

United States

资讯

查看全部 3449 →

去年

Novel Panic Disorder Treatment HB-1 Enters Nationwide Clinical Trial in Australia

4个月前

Antibiotic Minocycline Shows Promise as Novel Treatment for Panic Disorder in Clinical Trial

去年

临床试验

Therapies for Treatment-Resistant Panic Disorder Symptoms

Interactive Computer Treatment for Panic Disorder

Efficacy of Treatment for Panic Disorder

药物

Fluoxetine(Prozac, Sarafem, Symbyax)

Venlafaxine(Effexor)

Paroxetine(Paxil, Pexeva)

机构

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

Vanda Pharmaceuticals

Alzamend Neuro

资讯

Novel Panic Disorder Treatment HB-1 Enters Nationwide Clinical Trial in Australia

Antibiotic Minocycline Shows Promise as Novel Treatment for Panic Disorder in Clinical Trial

InhaleRx Secures $38.5 Million Funding to Advance Novel Inhaled Therapies for Cancer Pain and Panic Disorder